2025 Allied Health Professionals Meeting On-Demand Package

Log in to see your correct pricing, as early-bird pricing is open through October 19! SGO members receive a discount. Content will be made available by October 20. Meeting attendees will automatically be enrolled once the content becomes available.

This course includes CE-eligible sessions recorded at the SGO 2025 Allied Health Professionals Meeting held in Denver, Colorado on October 10-12, 2025. CE (11.25) is available for this content through April 20, 2026. After that date registrants of the course will still be able to access the content.

  • Best of SGO & Latest Updates - Amanda Fader, MD 
  • Clinical Trial Interpretation: How to Break it Down & Apply to Our Practice - Brad Corr & Lisa Babayan, PA-C
  • Genetics, Molecular Profiling, and ctDNA - Terri Earles, DNP, APRN, WHNP-BC, Melinda Simonson, CGC, Kathleen Lutz, RN, NP-C WH
  • Insight Into Difficult Conversations in Gyn Onc: Overview of MAID - Danielle Blemur, MD, MPH
  • More than Medicine: Professionalism in Cancer Career - Sarah Bernstein, MD
  • Stoma Sense: Smart Strategies for Ostomy Indications and Care - Yovanni Casablanca, MD 
  • Pins and Needles: Management of Neuropathy - Yingrong Zhu, MD 
  • Treatment Sequencing: What's Next? - Erin Medlin, MD
  • Wellness: Care for the Caregivers - Elizabeth Chamberlain, PhD
  • Prevention and Management of Post-operative Nausea: In Patient Considerations - Robin Lacour, MD5
  • From Diagnosis to Recovery: Optimizing the Patient Experience in Radiation Oncology for Gynecologic Cancers - Andrzej Wojcieszynski, MD

Target Audience

Nurse Practitioners, Physician Assistants/Associates, APPs, NPs, PAs, SGO Members

Learning Objectives

1. Demonstrate advanced medical knowledge of current and emerging concepts in gynecologic oncology, including treatment sequencing, molecular profiling, and clinical trial interpretation, to inform evidence-based patient management. 

2. Interpret diagnostic tools and clinical data—including imaging, genetic testing, and circulating tumor DNA (ctDNA)—to better understand accurate diagnosis, prognosis, and therapeutic decision-making.n.

3. Enhance clinical reasoning and practice-based strategies to recognize, manage, and mitigate treatment-related complications such as neuropathy, ostomy-related challenges, and post-operative nausea.

Additional Information

AttachmentSize
PDF icon Schedule197.08 KB
PDF icon Learner Notification318.16 KB

You may also be interested in

2025 Basics Bootcamp: Women's Wellness: Hormones, the Pause, and Sexual Health for Gyn Cancer Survivors
Participants will gain practical strategies to optimize quality of life and support holistic care for patients throughout cancer treatment and beyond.
2024 Targeted Therapy Advanced Bootcamp
This course is recommended for any allied health member giving chemotherapy, particularly those with at least three years of experience working in gyn onc.
APP Onboarding Tool
Newly-updated guide for onboarding APPs new to gynecologic oncology.
Course summary
Available credit: 
  • 11.25 AMA PRA Category 1 Credit™
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Amedco LLC designates this Enduring material for a maximum of 11.25 Enduring AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 11.25 AMA PRA Category 1 Credits™- For Non-physicians
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    PAs may claim a maximum of 11.25 Enduring Category 1 credits for completing this activity.
  • 11.25 CNE Contact Hours
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Amedco LLC designates this activity for a maximum of 11.25 Enduring ANCC contact hours.
  • 11.25 Participation
Course opens: 
10/03/2025
Course expires: 
10/12/2028
Cost:
$425.00

Available Credit

  • 11.25 AMA PRA Category 1 Credit™
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Amedco LLC designates this Enduring material for a maximum of 11.25 Enduring AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 11.25 AMA PRA Category 1 Credits™- For Non-physicians
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    PAs may claim a maximum of 11.25 Enduring Category 1 credits for completing this activity.
  • 11.25 CNE Contact Hours
    In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Amedco LLC designates this activity for a maximum of 11.25 Enduring ANCC contact hours.
  • 11.25 Participation

Price

Cost:
$425.00
Please login or register to take this course.